Diagnostic and Biotech

2016 Clinical Chemistry and Immunodiagnostic Testing in the US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

  • VPG347148
  • 635 Pages
  • October 2015
  • Diagnostic and Biotech

Complete report $11,500. DataPack (test volumes, sales forecasts, supplier shares) $7,500.


2016 Clinical Chemistry and Immunodiagnostic Testing in the US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations is a new strategic analysis of major business opportunities emerging in the US clinical chemistry and immunodiagnostic hospital, commercial and point-of-care/POC markets during the nextfive years. The report explores future trends in the US market; provides estimates of the specimen, test and sales volumes, as well as major suppliers sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.


The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, ER, OR, ICU, cancer clinics, ambulatory care centers, surgery centers, nursing hones, and birth centers, including controls, calibrators and consumables.


Rationale


The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.


Strategic Recommendations


- New product development opportunities

with significant market appeal.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Tests Analyzed in the Report


Routine Clinical Chemistry


Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total,

BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride,

Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose,

HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus,

Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid.


Therapeutic Drug Monitoring (TDM)


Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam,

Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus,

Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.


Endocrine Function


Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH,

Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone,

Thyroglobulin Ab, TPO Ab, TSH.


Tumor Markers and Special Chemistry


AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid),

Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood,

PAP, PSA, Thyroglobulin, Vitamin B-12.


Immunoproteins


C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM,

Immunofixation, Prealbumin, Protein Electrophoresis.


Drugs of Abuse


Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine,

LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP),

Propoxyphene, Tricyclic Antidepressants.


Market Segmentation Analysis


- Comprehensive review of the market

dynamics, trends, structure, size, growth,

and key suppliers.


- Test volume and sales forecasts for over 100 clinical chemistry,

TDM, endocrine, cancer, immunoprotein and abused drug assays,

by market segment:



Centralized Testing



- Hospitals

- Commercial/Private Laboratories


POC/Decentralized Testing


- Physician Offices/Group Practices

- Emergency Rooms

- Operating/Recovery Suites

- ICUs/CCUs

- Cancer Clinics

- Ambulatory Care Centers

- Surgery Centers

- Nursing Homes

- Birth Centers



Current and Emerging Products


- Analysis of current and emerging clinical chemistry

and immunodiagnostic tests.


- Review of current instrumentation technologies, and feature comparison

of high-, medium-, and low-volume/POC analyzers.


Technology Review


- Assessment of current and emerging

technologies, and their potential market applications.


- Comprehensive lists of companies developing

or marketing new technologies and products by test.


Competitive Strategies


- Strategic assessments of major suppliers and

emerging market entrants, including their sales, product

portfolios, marketing tactics, collaborative

arrangements and new products in R&D.


- The companies analyzed in the report include:


- Abbott

- AdnaGen

- Agilent Technologies


- Bayer Healthcare

- Beckman Coulter/Danaher

- Biomedical Diagnostics

- Biomerieux

- Bio-Rad

- Diasorin

- Eiken Chemical

- Fujirebio

- Grifols

- Instrumentation Laboratory

- Kyowa Medex

- Matritech/Alere

- Ortho-Clinical Diagnostics

- Quest Diagnostics

- Roche

- Siemens

- Sysmex

- ThermoFisher

- Tosoh

- Wako

- Wallac/PE


Contains 635 pages and 149 tables

Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Exocrine Pancreatic Insufficiency Market (Mode of Disease management, Type of diagnostic tests and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2021

Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas. EPI is commonly found in humans affected with Shwachman-Diamond ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Epigenetics Market - Opportunities and Forecasts, 2015 - 2020

Epigenetics, in the field of genetics, involves study of cellular and physiological trait variations initiated by external or ecological aspects which swipe genes on and off and affect how cells ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Microbial Identification Market - Opportunities and Forecasts, 2014 - 2020

Microbial identification is a technique used to get characterization of the microbes and their relation with environment. It is of utmost important as microbes can easily contaminate production facilities, products ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Plasma Fractionation Market - Opportunities and Forecasts, 2015 - 2020

Plasma fractionation is a process of separating various components of plasma. It is used in in prevention and treatment of life threatening diseases caused by trauma, immunologic disorders, and infections. ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Enteric Disease Testing Market (Therapeutics, Technologies and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Enteric disease is a condition caused in the intestine due to the presence of foreign antigen such as bacterial, viral and parasites. The enteric diseases are commonly caused due to ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Pyrogen Testing Market - Opportunities and Forecast, 2015 - 2020

Pyrogen is a thermostable bacterial toxin that induces immunogenic response when administered parenterally. Pyrogen testing is a process that determines the presence of bacterial toxins in vaccines, biotechnological products, and ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>